|
26 Companies |
|
51 Products |
|
51 Products |
|
56 Mechanisms of Action |
|
3 Trials |
|
839 News |
|
| «12345678910111213...1617» |
- Enrollment open, Trial primary completion date: Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study (clinicaltrials.gov) - Feb 21, 2016
P=N/A, N=40, Recruiting, Sponsor: Henri Mondor University Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2012 --> Nov 2016
- Trial primary completion date: Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome (clinicaltrials.gov) - Feb 17, 2016
P=N/A, N=54, Recruiting, Sponsor: Qingdao University
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2012 --> Nov 2016 Trial primary completion date: Aug 2016 --> Aug 2018
- fezagepras (PBI-4050) / Liminal BioSci
Trial primary completion date: Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome (clinicaltrials.gov) - Feb 17, 2016
P2, N=36, Recruiting, Sponsor: ProMetic BioSciences Inc.
Trial primary completion date: Aug 2016 --> Aug 2018 Trial primary completion date: Feb 2016 --> Sep 2016
- Trial completion: Study of Chronic Degenerative Diseases (clinicaltrials.gov) - Feb 17, 2016
P=N/A, N=57, Completed, Sponsor: Asociaci
Trial primary completion date: Feb 2016 --> Sep 2016 Recruiting --> Completed
- Trial completion: FRESH Start: A Novel Diet-Phenotype Interaction Affecting Body Weight (clinicaltrials.gov) - Feb 9, 2016
P=N/A, N=155, Completed, Sponsor: Children's Hospital Boston
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: ARMOPREVCVR: The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk (clinicaltrials.gov) - Feb 3, 2016
P4, N=150, Completed, Sponsor: Federico II University
Active, not recruiting --> Completed Recruiting --> Completed | N=1500 --> 150 | Trial primary completion date: Dec 2013 --> Oct 2014
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Enrollment open, Trial initiation date, Trial primary completion date: METALIP: Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=250, Recruiting, Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Recruiting --> Completed | N=1500 --> 150 | Trial primary completion date: Dec 2013 --> Oct 2014 Not yet recruiting --> Recruiting | Initiation date: Nov 2015 --> Feb 2016 | Trial primary completion date: Mar 2016 --> Jun 2016
- Kineret (anakinra) / SOBI
New P3 trial: TestIL: Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome (clinicaltrials.gov) - Feb 3, 2016
P3, N=50, Recruiting, Sponsor: Mirjam Christ-Crain
- New trial: The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study) (clinicaltrials.gov) - Jan 26, 2016
P=N/A, N=72, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- Trial completion, Enrollment change: OBEFITT: Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering From Metabolic Syndrome (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=79, Completed, Sponsor: University Hospital, Rouen
Not yet recruiting --> Recruiting | Initiation date: Nov 2015 --> Feb 2016 | Trial primary completion date: Mar 2016 --> Jun 2016 Active, not recruiting --> Completed | N=100 --> 79
- Biomarker, Trial primary completion date: NUTREND: Development of Endothelial Biomarkers (clinicaltrials.gov) - Jan 22, 2016
P=N/A, N=60, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
Active, not recruiting --> Completed | N=100 --> 79 Trial primary completion date: Jun 2015 --> Aug 2016
- fenofibrate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date, Adverse events: Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) (clinicaltrials.gov) - Jan 22, 2016
P=N/A, N=5, Terminated, Sponsor: Daewoong Pharmaceutical Co. LTD.
Trial primary completion date: Jun 2015 --> Aug 2016 N=1573 --> 5 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Sep 2014
- | Victoza (liraglutide) / Novo Nordisk
New P4 trial: MAGNA VICTORIA: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent (clinicaltrials.gov) - Jan 21, 2016
P4, N=50, Recruiting, Sponsor: Leiden University Medical Center
- Trial completion: Canola Oil, Fibre and DHA Enhanced Clinical Trial (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=30, Completed, Sponsor: University of Manitoba
N=1573 --> 5 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Sep 2014 Recruiting --> Completed
- | Trial completion: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (clinicaltrials.gov) - Jan 15, 2016
P3, N=60, Completed, Sponsor: Bambino Ges
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: EFIGRO: Effect of Exercise on Hepatic Fat in Overweight Children (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=160, Recruiting, Sponsor: Basque Country University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- New trial: Impact of Metabolic Syndrome on Flu Vaccine Efficacy (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=40, Not yet recruiting, Sponsor: Rockefeller University
- New trial: Oatmet: The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge (clinicaltrials.gov) - Jan 14, 2016
P=N/A, N=8, Enrolling by invitation, Sponsor: Institute of Food Research
- quetiapine / Generic mfg.
Trial completion, Enrollment change: The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=20, Completed, Sponsor: Creighton University
Not yet recruiting --> Recruiting Recruiting --> Completed | N=40 --> 20
- ||| New trial: Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=300, Recruiting, Sponsor: Yonsei University
- New trial: Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome (clinicaltrials.gov) - Jan 7, 2016
P=N/A, N=54, Recruiting, Sponsor: Qingdao University
- Enrollment closed, Trial primary completion date: Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) - Jan 5, 2016
P2, N=28, Active, not recruiting, Sponsor: Rockefeller University
Recruiting --> Completed | N=40 --> 20 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Aug 2015
- Enrollment closed, Trial primary completion date, HEOR, Cost effectiveness: The Flamenco (Fitness League Against MENopause COsts) Project (clinicaltrials.gov) - Jan 4, 2016
P=N/A, N=160, Active, not recruiting, Sponsor: Universidad de Granada
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Aug 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Nov 2015
- Trial completion: Assessing the Prevalence of Metabolic Syndrome in Renal Transplantation (clinicaltrials.gov) - Dec 16, 2015
P=N/A, N=200, Completed, Sponsor: University of Sao Paulo General Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Nov 2015 Recruiting --> Completed
- | metformin / Generic mfg.
New P2 trial: Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome (clinicaltrials.gov) - Dec 14, 2015
P2, N=104, Not yet recruiting, Sponsor: Centro Universitario de Ciencias de la Salud, Mexico
- New trial: Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome (clinicaltrials.gov) - Dec 9, 2015
P=N/A, N=9, Completed, Sponsor: Katholieke Universiteit Leuven
- Trial primary completion date, Surgery, Bariatric surgery: ADIII: Effect of Bariatric Surgery "Digestive Adaptations III" on Cardiovascular Risk (clinicaltrials.gov) - Dec 6, 2015
P2, N=30, Active, not recruiting, Sponsor: University of Sao Paulo
Recruiting --> Completed Trial primary completion date: Sep 2015 --> Mar 2016
- Enrollment status, Trial primary completion date: Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation (clinicaltrials.gov) - Dec 5, 2015
P3, N=118, Enrolling by invitation, Sponsor: Vanderbilt University
Trial primary completion date: Sep 2015 --> Mar 2016 Recruiting --> Enrolling by invitation | Trial primary completion date: Jul 2016 --> Dec 2017
- Trial suspension, HEOR: ENDOMETAB: ENDOBARRIER (clinicaltrials.gov) - Dec 5, 2015
P1/2, N=174, Suspended, Sponsor: University Hospital, Lille
Recruiting --> Enrolling by invitation | Trial primary completion date: Jul 2016 --> Dec 2017 Recruiting --> Suspended
- || aripiprazole / Generic mfg.
Trial primary completion date: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=90, Recruiting, Sponsor: University of British Columbia
Recruiting --> Suspended Trial primary completion date: Sep 2015 --> Sep 2016
- Trial completion: An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=47, Completed, Sponsor: Lund University
Trial primary completion date: Sep 2015 --> Sep 2016 Active, not recruiting --> Completed
- Trial primary completion date: Effects of Almond Intake on Atherogenic Lipoprotein Particles (clinicaltrials.gov) - Nov 27, 2015
P=N/A, N=40, Recruiting, Sponsor: Children's Hospital & Research Center Oakland
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Jun 2016
- Viracept (nelfinavir) / ViiV Healthcare, Roche
New trial: METALIP: Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances (clinicaltrials.gov) - Nov 25, 2015
P=N/A, N=250, Not yet recruiting, Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
- Enrollment change: PilAm Go4Health Weight Loss Program to Prevent Heart Disease (clinicaltrials.gov) - Nov 21, 2015
P=N/A, N=50, Recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Dec 2015 --> Jun 2016 N=40 --> 50
- | New P2 trial: The Effect of Hesperidin on Glucose / Insulin Metabolism (clinicaltrials.gov) - Nov 21, 2015
P2, N=53, Completed, Sponsor: Maastricht University Medical Center
- omega-3 ethylester concentrate / Generic mfg.
Trial primary completion date: HEARTS: Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (clinicaltrials.gov) - Nov 16, 2015
P3, N=338, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
N=40 --> 50 Trial primary completion date: May 2015 --> May 2016
- New trial: Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome (clinicaltrials.gov) - Nov 16, 2015
P0, N=60, Completed, Sponsor: Shanghai University of Traditional Chinese Medicine
- Trial completion, Enrollment change, Trial primary completion date: Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis (clinicaltrials.gov) - Nov 5, 2015
P=N/A, N=39, Completed, Sponsor: Pontificia Universidad Catolica de Chile
Trial primary completion date: May 2015 --> May 2016 Recruiting --> Completed | N=60 --> 39 | Trial primary completion date: Oct 2015 --> Apr 2015
- triptorelin / Generic mfg.
Trial completion, Enrollment change: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism (clinicaltrials.gov) - Oct 28, 2015
P4, N=31, Completed, Sponsor: Herlev Hospital
Recruiting --> Completed | N=60 --> 39 | Trial primary completion date: Oct 2015 --> Apr 2015 Active, not recruiting --> Completed | N=20 --> 31
- ||| Trial completion: ARMP-11: Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Oct 27, 2015
P=N/A, N=159, Completed, Sponsor: Rottapharm
Active, not recruiting --> Completed | N=20 --> 31 Active, not recruiting --> Completed
- Enrollment closed, Enrollment change, Trial primary completion date: Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) (clinicaltrials.gov) - Oct 26, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: St. Jude Medical
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=60 --> 20 | Trial primary completion date: Sep 2015 --> Mar 2016
- Kineret (anakinra) / SOBI
Trial primary completion date: CortIL: Effects of IL-1 Beta on the HPA-axis in Obese Persons (clinicaltrials.gov) - Oct 22, 2015
P3, N=69, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Active, not recruiting | N=60 --> 20 | Trial primary completion date: Sep 2015 --> Mar 2016 Trial primary completion date: Oct 2015 --> Mar 2016
- Biomarker, Trial completion: STAR: Soybean Oil Trial of cArdiovascular Risk (clinicaltrials.gov) - Oct 16, 2015
P=N/A, N=60, Completed, Sponsor: USDA Beltsville Human Nutrition Research Center
Trial primary completion date: Oct 2015 --> Mar 2016 Active, not recruiting --> Completed
- Enrollment closed: Health Improvement After Pregnancy (HIP) Program Randomized Control Trial (clinicaltrials.gov) - Oct 15, 2015
P=N/A, N=96, Active, not recruiting, Sponsor: Queen's University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion, Enrollment change: Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=1800, Completed, Sponsor: Korea University
Recruiting --> Active, not recruiting Recruiting --> Completed | N=1000 --> 1800
- Trial completion: Risk Factor Analysis for Coronary Atherosclerosis Measured by MDCT (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=150, Completed, Sponsor: Korea University
Recruiting --> Completed | N=1000 --> 1800 Recruiting --> Completed
- | Victoza (liraglutide) / Novo Nordisk
Enrollment closed, Trial primary completion date: MAGNA VICTORIA: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients (clinicaltrials.gov) - Oct 13, 2015
P4, N=50, Active, not recruiting, Sponsor: Leiden University Medical Center
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
- | Trial completion, Enrollment change, Trial primary completion date: The Organ Protection of Astragalus in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Oct 9, 2015
P3, N=210, Completed, Sponsor: LanZhou University
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Completed | N=420 --> 210 | Trial primary completion date: Dec 2013 --> Jun 2015
- Trial completion: Acute Effects of Tocotrienols on Insulin Sensitivity and Metabolic Risk Markers in Individuals at Risk for Metabolic Syndrome (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=30, Completed, Sponsor: Malaysia Palm Oil Board
Recruiting --> Completed | N=420 --> 210 | Trial primary completion date: Dec 2013 --> Jun 2015 Recruiting --> Completed
- Trial initiation date: Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (clinicaltrials.gov) - Oct 6, 2015
P1/2, N=21, Not yet recruiting, Sponsor: Lawson Health Research Institute
Recruiting --> Completed Initiation date: Sep 2015 --> Jan 2016